Heart-lung Machine Market, By Product, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

REPORT HIGHLIGHT

Heart-lung Machine Market size was valued at USD 2,162.43 Million in 2024, expanding to a CAGR of 6.12% from 2025 to 2032.

A heart-lung machine, also called a cardiopulmonary bypass (CPB) machine, is a medical device used during open-heart surgery to temporarily take over the function of the heart and lungs. It pumps oxygenated blood throughout the body while the heart is stopped, allowing surgeons to operate on a still and bloodless heart. The machine removes carbon dioxide from the blood, adds oxygen, and maintains proper blood pressure, flow, and temperature. It consists of a pump, an oxygenator, heat exchanger, and various monitoring systems to ensure safety. The heart-lung machine is essential for procedures such as coronary artery bypass grafting, heart valve repair, etc.

Heart-lung Machine Market- Market Dynamics
Increasing prevalence of cardiovascular diseases and technological advancements in oxygenators and connected platforms are expected to propel market demand

The global rise in cardiovascular diseases (CVDs), including coronary artery disease, valvular disorders, and heart failure, is a major health concern, representing one of the leading causes of death worldwide, boosting the demand for heart-lung machines, thereby fueling market growth. Millions of people are affected due to factors such as aging populations, sedentary lifestyles, poor dietary habits, obesity, and high blood pressure. As the prevalence of these conditions grows, the demand for cardiac surgeries such as coronary artery bypass grafting (CABG), heart valve repair, and other complex thoracic procedures also increases. These surgeries often require extracorporeal circulatory support, making heart-lung machines indispensable, as they temporarily assume the functions of the heart and lungs. This allows surgeons to operate on a still heart while maintaining controlled blood oxygenation and circulation. The number of open-heart surgeries has been steadily rising across key regions, particularly in North America and Europe, with rapid growth now observed in the Asia-Pacific region. This trend is driving the need for more advanced, reliable heart-lung machines and related consumables, fueling innovation and market growth.

Manufacturers are increasingly integrating advanced features into heart-lung machines, including enhanced oxygenators, automated perfusion controls, real-time monitoring, AI-enabled safety systems, and more compact, user-friendly designs. These technological improvements enhance precision, minimize complications such as hemolysis and inflammatory responses, and support better surgical outcomes. Portable and emergency-ready systems extend the use of these machines beyond traditional operating rooms, while sophisticated monitoring capabilities allow surgeons to handle complex procedures with greater accuracy.

Heart-lung Machine Market- Segmentation Analysis:

The Global Heart-lung Machine Market is segmented on the basis of Product, Application, End User, and Region.

The market is divided into two categories based on Product: capital equipment and consumables. Consumables segment held a substantial share with high demand for cannulas, oxygenators, and other accessories. These items are single-use or limited-use components, which need regular replacement for each surgery, ensuring consistent revenue generation. Among these, cannulas and oxygenators are particularly critical, as they directly impact blood flow efficiency, oxygenation, and patient safety during cardiopulmonary bypass procedures. The rising number of open-heart surgeries, along with growing awareness of infection control and the need for high-performance, reliable consumables, has further boosted segment demand.

The market is divided into five categories based on Application: cardiac surgeries, heart transplants, lung transplants, heart valve surgeries, and others. The cardiac surgeries segment holds the largest share of the heart-lung machine market, driven by the high volume of procedures such as coronary artery bypass grafting (CABG), heart valve repair and replacement, and other complex open-heart surgeries. These procedures rely heavily on heart-lung machines, as they temporarily take over the functions of the heart and lungs, allowing surgeons to operate on a still and bloodless heart. The prevalence of cardiovascular diseases, especially in aging populations and regions with high incidences of coronary artery disease and valvular disorders, has led to a steady increase in the number of surgical interventions.

Heart-lung Machine Market- Geographical Insights

Across the globe, the Heart-lung Machine market is split in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America held majority share in the heart-lung machine market, driven by advanced healthcare infrastructure, high awareness of cardiac care, a large patient population requiring open-heart surgeries, and significant investments in cutting-edge medical technologies. The region benefits from well-established cardiac centers, robust research and development activities, and widespread adoption of technologically advanced surgical devices. Europe also maintains a substantial market share, supported by mature healthcare systems, government initiatives promoting cardiac care, a growing elderly population, and rising prevalence of cardiovascular diseases, which together drive demand for heart-lung machines. In Asia Pacific, countries such as China, India, and Japan are witnessing a surge in open-heart surgeries and greater adoption of advanced heart-lung systems.

India Heart-lung Machine Market- Key Insights

The United States significant market share for heart-lung machines globally, driven by its advanced healthcare infrastructure, high prevalence of cardiovascular diseases, and significant number of open-heart surgeries performed every year. Hospitals and specialized cardiac centers in the U.S. widely adopt heart-lung machines to support procedures such as coronary artery bypass grafting, valve repair, and complex thoracic surgeries, ensuring patient safety and optimal surgical outcomes. The market is further propelled by technological advancements, including AI-assisted monitoring, automated perfusion systems, and improved oxygenators, which enhance procedural efficiency and reduce complications. Additionally, favorable reimbursement policies, strong healthcare funding, and investments in upgrading surgical equipment support steady market growth. The American Heart Association (AHA) Cardiovascular‑Kidney‑Metabolic Health Initiative expands awareness, screening, and treatment in numerous states in the U.S.

Heart-lung Machine Market- Competitive Landscape:

The heart-lung machine market is moderately consolidated. Leading companies compete by leveraging continuous innovation, advanced R&D capabilities, and strategic collaborations, which allow them to introduce cutting-edge technologies such as AI-enabled monitoring, automated perfusion systems, and compact or portable devices. Additionally, these players maintain extensive global distribution networks, enabling wide adoption of their products across hospitals, cardiac centers, etc. Small-sized companies often focus on cost-effective solutions, consumables, or region-specific technologies, creating niche opportunities for market growth.

Recent Developments:

In 2025, LivaNova strengthened its market position by launching the Essenz Perfusion System in China after receiving regulatory approval, markedly enhancing its presence in this fast-growing and strategic market.
In September 2024, Medtronic plc introduced VitalFlow, a versatile, single-platform ECMO system designed to seamlessly support both bedside care and intra-hospital patient transport, emphasizing ease of use, reliability, and high performance.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HEART-LUNG MACHINE MARKET KEY PLAYERS

LivaNova PLC
Medtronic PLC
Getinge AB
Terumo Corporation
Nipro Corporation
Braile Biomedica
Tianjin Medical Equipment Co., Ltd.
Hemovent GmbH
Elite Lifecare
Sorin Group
Abbott Laboratories
Fresenius Kabi
EBS Technologies
Medos Medizintechnik AG
Cardiomedical AG
Others

GLOBAL HEART-LUNG MACHINE MARKET, BY PRODUCT- MARKET ANALYSIS, 2019-2032

Capital Equipment
Pumps
Heat Exchangers
Monitoring Systems
Consumables
Cannulas
Oxygenators
Blood reservoir
Accessories

GLOBAL HEART-LUNG MACHINE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

Cardiac surgeries
Coronary Artery Bypass Grafting (CABG)
Valve repair
Heart transplant
Lung transplant
Others

GLOBAL HEART-LUNG MACHINE MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

Hospitals
Ambulatory Surgical Centers
Research Institutes
Others

GLOBAL HEART-LUNG MACHINE MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt Show more